Winthrop Partners - WNY’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Hold
2,722
0.17% 73
2026
Q1
$327K Hold
2,722
0.17% 74
2025
Q4
$287K Buy
+2,722
New +$256K 0.15% 76
2019
Q3
$3.87M Buy
48,160
+1,015
+2% +$81.3K 2.61% 6
2019
Q2
$3.77M Buy
47,145
+2,130
+5% +$163K 2.83% 5
2019
Q1
$3.58M Buy
45,015
+1,679
+4% +$126K 2.79% 5
2018
Q4
$3.16M Buy
43,336
+53
+0.1% +$3.74K 2.95% 5
2018
Q3
$2.93M Buy
43,283
+2,921
+7% +$186K 2.37% 6
2018
Q2
$2.34M Buy
40,362
+578
+1% +$32.6K 1.94% 12
2018
Q1
$2.13M Buy
39,784
+178
+0.4% +$9.61K 1.64% 15
2017
Q4
$2.08M Buy
+39,606
New +$2.2M 1.7% 20

Other funds holding MRK

Winthrop Partners - WNY's MRK Position: Q2 2026 in Review

Winthrop Partners - WNY held its Merck (MRK) position steady in Q2 2026 at 2,722 shares worth $350K. The position accounts for 0.17% of the portfolio, ranked #73.

Winthrop Partners - WNY first reported a position in MRK in Q4 2017 and has held it in 11 quarters since. The position peaked at $3.87M in Q3 2019. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Winthrop Partners - WNY held 2,722 shares of Merck worth $350K as of Q2 2026.
  • Winthrop Partners - WNY left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.17% of Winthrop Partners - WNY's portfolio in Q2 2026, its #73 holding.
  • Winthrop Partners - WNY first reported a position in Merck in Q4 2017 and has held it in 11 quarters since.
  • Winthrop Partners - WNY's Merck position peaked at $3.87M in Q3 2019.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Winthrop Partners - WNY's 13F filing for Q2 2026, filed 15 Jul 2026.